268
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Congenital Nasolacrimal Duct Obstruction – Early Diagnosis and Graded Therapeutic Approach as Key Points for Successful Management

Received 04 Apr 2024, Accepted 17 May 2024, Published online: 24 May 2024

Figures & data

Figure 1. Factors affecting the therapeutic decision in children with congenital nasolacrimal duct obstruction.

Figure 1. Factors affecting the therapeutic decision in children with congenital nasolacrimal duct obstruction.

Figure 2. Mucopurulent discharge upon lacrimal sac compression.

Figure 2. Mucopurulent discharge upon lacrimal sac compression.

Table 1. Selection of possible differential diagnoses of epiphora due to congenital dacryostenosis (modified from [9]).

Table 2. Classification of lacrimal stenosis.

Figure 3. Localization of stenosis in regard to the lacrimal sac.

Figure 3. Localization of stenosis in regard to the lacrimal sac.

Figure 4. Lacrimal fistula and its surgical treatment.

a) Fistula duct (arrow) in projection to the canaliculus lacrimalis communis
b) Fistula excision after prior preparation of the lacrimal intubation
c) Fistula closure by suture
d) Skin suture and monocanaliculonasal lacrimal intubation inserted in the superior lacrimal punctum.
Figure 4. Lacrimal fistula and its surgical treatment.

Figure 5. Lacrimal probing and syringing under local anesthesia (upper row) and general anesthesia (lower row).

From left to right: dilating the superior lacrimal punctum; inserting Bangerter’s cannula vertically into the lacrimal ampulla; probing the canaliculus until hard stop; further probing until reaching Hasner’s membrane after bringing the cannula in an upright position.
Figure 5. Lacrimal probing and syringing under local anesthesia (upper row) and general anesthesia (lower row).

Figure 6. Instruments and materials for lacrimal syringing (glucose 40% solution, sponges, local anesthetic eye drops, probe for dilatation, syringe with Bangerter’s cannula and saline solution).

Figure 6. Instruments and materials for lacrimal syringing (glucose 40% solution, sponges, local anesthetic eye drops, probe for dilatation, syringe with Bangerter’s cannula and saline solution).

Figure 7. Monocanaliculonasal intubation in an 18-month-old child (left eye).

a) Insertion of the Ritleng’s probe into the nasolacrimal duct after opening the Hasner’s membrane
b) Black thread inside the Ritleng-Probe
c) Pulling the thread out of the nose using a special hook
d) Pulling the silicone tube into the lacrimal ducts
e) Positioning of the plug of the lacrimal intubation into the lacrimal punctum.
Figure 7. Monocanaliculonasal intubation in an 18-month-old child (left eye).

Figure 8. Dacryoendoscopy in a 14-month-old child (left eye).

a) Positioning of the adstringent nose tamponades into the inferior and middle turbinate
b) Insertion of the dacryoendoscope into the canaliculus lacrimalis superior
c) Dacryoendoscopy of the lacrimal sac
d) Opening Hasner’s membrane under visual control by dacryoendoscopic guided probing
e) Dacryoendoscopic findings (from left to right): regular appearance of the canaliculus; polypous mucose (stars) as a sign of inflammation; view to the bottom of the lacrimal sac after Hasner’s membrane was opened; mucosa of the nose (hard palate).
Figure 8. Dacryoendoscopy in a 14-month-old child (left eye).

Figure 9. Transcutaneous dacryocystorhinostomy.

a) Skin incision over the anterior lacrimal crest
b) Preparation of the osteotomy
c) Suturing mucosal flaps of the lacrimal sac and the nose (sacconasal mucosal anastomosis)
d) Findings after skin closure.
Figure 9. Transcutaneous dacryocystorhinostomy.

Table 3. Staged therapeutic concept for Congenital Dacryostenosis [12].